Drug search by name

Reglan (Metoclopramide Injection Solution) and Fluid retention

Result of checking the interaction of drug Reglan (Metoclopramide Injection Solution) and disease Fluid retention for safety when used together.

Check result:

Reglan (Metoclopramide Injection Solution) <> Fluid retention

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Metoclopramide produces a transient increase in plasma aldosterone and may cause fluid retention and volume overload in susceptible patients. Therapy with metoclopramide should be administered cautiously in patients with or at risk for fluid overload (e.g., cirrhosis, congestive heart failure). If these side effects occur at any time during metoclopramide therapy, the drug should be discontinued.

References:

"Product Information. Reglan (metoclopramide)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Ahmad S "Metoclopramide-induced acute congestive heart failure." South Med J 84 (1991): 283-4

Reglan (Metoclopramide Injection Solution)

Generic Name: metoclopramide

Brand Name: Reglan, Metozolv ODT

Synonyms: Reglan

What is Reglan (Metoclopramide Injection Solution)?